Business
Vaccine ‘not a panacea’ as surgeries bounce back: Cochlear boss – Sydney Morning Herald
The hearing implant maker is still on the long path back to a COVID normal but can see some light at the end of the tunnel.
When asked exactly how long it will be before all markets had recovered to the same or better levels than before the pandemic, Mr Howitt said it was more likely to be years than months. I think the thing is that the bigger markets where we are in have bounced back quickly, so that is what gives us some confidence. But I think the tail could be quite long.
Cochlears sales in emerging regions, including Latin America and Brazil, were down 30 per cent for the first half (year-on-year), while sales…
-
General23 hours agoTyler Wright soaks up Bells Beach return as poor conditions at Rip Curl Pro sees men’s opening round called off
-
General23 hours agoTruck driver charged with causing death by dangerous driving after highway crash
-
Noosa News21 hours agoGyrocopter pilot injured in crash-landing on K’Gari, north of Brisbane
-
General24 hours agoIndonesia to increase US imports and lower other orders